3D Printing services, product reviews,market estimates forecasts, stocks
According to Sam Davies, “We are developing a new wave of solutions that have the potential to transform how we heal injury and disease.”
According to Tamer Mohamed, CEO, Aspect Biosystems, “We are thrilled to close this important institutional financing round with a group of world-class investors who believe in our bold vision. This funding speaks to the power of our technology and strategy in addressing multiple applications in therapeutic discovery and regenerative medicine, and will allow us to accelerate internal innovation and expand our global partnerships. With our technology platform, interdisciplinary team of scientists and engineers, and leading collaborators, we are developing a new wave of solutions that have the potential to transform how we heal injury and disease.”
According to Jordan Jacobs, managing partner, Radical Ventures, “We are very excited to partner with the excellent Aspect team to support the growth of their world-leading 3D bioprinting platform and the development of breakthrough technologies aimed at radically transforming human health.
In the opinion of Lead author and Ph.D. candidate from RMIT University’s School of Engineering, Carmelo Todaro, “the promising results could inspire new forms of additive manufacturing.
If you look at the microscopic structure of 3-D printed alloys, they’re often made up of large and elongated crystals.
This can make them less acceptable for engineering applications due to their lower mechanical performance and increased tendency to crack during printing.
But the microscopic structure of the alloys we applied ultrasound to during printing looked markedly different: the alloy crystals were very fine and fully equiaxed, meaning they had formed equally in all directions throughout the entire printed metal part.”